Cargando…

Influence of Maternal Gestational Treatment with Mycobacterial Antigens on Postnatal Immunity in an Experimental Murine Model

BACKGROUND: It has been proposed that the immune system could be primed as early as during the fetal life and this might have an impact on postnatal vaccination. Therefore, we addressed in murine models whether gestational treatment with mycobacterial antigens could induce better immune responses in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Muhammad Jubayer, Dégano, Irene Roman, Singh, Mahavir, Fernández, Carmen
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837747/
https://www.ncbi.nlm.nih.gov/pubmed/20300629
http://dx.doi.org/10.1371/journal.pone.0009699
_version_ 1782178849545519104
author Rahman, Muhammad Jubayer
Dégano, Irene Roman
Singh, Mahavir
Fernández, Carmen
author_facet Rahman, Muhammad Jubayer
Dégano, Irene Roman
Singh, Mahavir
Fernández, Carmen
author_sort Rahman, Muhammad Jubayer
collection PubMed
description BACKGROUND: It has been proposed that the immune system could be primed as early as during the fetal life and this might have an impact on postnatal vaccination. Therefore, we addressed in murine models whether gestational treatment with mycobacterial antigens could induce better immune responses in the postnatal life. METHODS/FINDINGS: BALB/c mice were treated subcutaneously (s.c.) at the second week of gestation with antigen (Ag)85A or heparin-binding hemagglutinin (HBHA) in the absence of adjuvant. Following birth, offspring mice were immunized intranasally (i.n.) with the same antigens formulated with the adjuvant cholera toxin (CT) at week 1 and week 4. One week after the last immunization, we assessed antigen-specific recall interferon gamma (IFN-γ) responses by in vitro restimulation of lung-derived lymphocytes. Protection against infection was assessed by challenge with high dose Mycobacterium bovis Bacille Calmette-Guérin (BCG) given i.n. We found that recall IFN-γ responses were higher in the offspring born to the treated mother compared to the untreated-mother. More importantly, we observed that the offspring born to the treated mother controlled infection better than the offspring born to the untreated mother. Since the gestational treatment was done in absence of adjuvant, essentially there was no antibody production observed in the pregnant mice and therefore no influence of maternal antibodies was expected. We hypothesized that the effect of maternal treatment with antigen on the offspring occurred due to antigen transportation through placenta. To trace the antigens, we conjugated fluorescent nanocrystals with Ag85A (Qdot-ITK-Ag85A). After inoculation in the pregnant mice, Qdot-ITK-Ag85A conjugates were detected in the liver, spleen of pregnant females and in all the fetuses and placentas examined. CONCLUSION: The fetal immune system could be primed in utero by mycobacterial antigens transported through the placenta.
format Text
id pubmed-2837747
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-28377472010-03-18 Influence of Maternal Gestational Treatment with Mycobacterial Antigens on Postnatal Immunity in an Experimental Murine Model Rahman, Muhammad Jubayer Dégano, Irene Roman Singh, Mahavir Fernández, Carmen PLoS One Research Article BACKGROUND: It has been proposed that the immune system could be primed as early as during the fetal life and this might have an impact on postnatal vaccination. Therefore, we addressed in murine models whether gestational treatment with mycobacterial antigens could induce better immune responses in the postnatal life. METHODS/FINDINGS: BALB/c mice were treated subcutaneously (s.c.) at the second week of gestation with antigen (Ag)85A or heparin-binding hemagglutinin (HBHA) in the absence of adjuvant. Following birth, offspring mice were immunized intranasally (i.n.) with the same antigens formulated with the adjuvant cholera toxin (CT) at week 1 and week 4. One week after the last immunization, we assessed antigen-specific recall interferon gamma (IFN-γ) responses by in vitro restimulation of lung-derived lymphocytes. Protection against infection was assessed by challenge with high dose Mycobacterium bovis Bacille Calmette-Guérin (BCG) given i.n. We found that recall IFN-γ responses were higher in the offspring born to the treated mother compared to the untreated-mother. More importantly, we observed that the offspring born to the treated mother controlled infection better than the offspring born to the untreated mother. Since the gestational treatment was done in absence of adjuvant, essentially there was no antibody production observed in the pregnant mice and therefore no influence of maternal antibodies was expected. We hypothesized that the effect of maternal treatment with antigen on the offspring occurred due to antigen transportation through placenta. To trace the antigens, we conjugated fluorescent nanocrystals with Ag85A (Qdot-ITK-Ag85A). After inoculation in the pregnant mice, Qdot-ITK-Ag85A conjugates were detected in the liver, spleen of pregnant females and in all the fetuses and placentas examined. CONCLUSION: The fetal immune system could be primed in utero by mycobacterial antigens transported through the placenta. Public Library of Science 2010-03-15 /pmc/articles/PMC2837747/ /pubmed/20300629 http://dx.doi.org/10.1371/journal.pone.0009699 Text en Rahman et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Rahman, Muhammad Jubayer
Dégano, Irene Roman
Singh, Mahavir
Fernández, Carmen
Influence of Maternal Gestational Treatment with Mycobacterial Antigens on Postnatal Immunity in an Experimental Murine Model
title Influence of Maternal Gestational Treatment with Mycobacterial Antigens on Postnatal Immunity in an Experimental Murine Model
title_full Influence of Maternal Gestational Treatment with Mycobacterial Antigens on Postnatal Immunity in an Experimental Murine Model
title_fullStr Influence of Maternal Gestational Treatment with Mycobacterial Antigens on Postnatal Immunity in an Experimental Murine Model
title_full_unstemmed Influence of Maternal Gestational Treatment with Mycobacterial Antigens on Postnatal Immunity in an Experimental Murine Model
title_short Influence of Maternal Gestational Treatment with Mycobacterial Antigens on Postnatal Immunity in an Experimental Murine Model
title_sort influence of maternal gestational treatment with mycobacterial antigens on postnatal immunity in an experimental murine model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837747/
https://www.ncbi.nlm.nih.gov/pubmed/20300629
http://dx.doi.org/10.1371/journal.pone.0009699
work_keys_str_mv AT rahmanmuhammadjubayer influenceofmaternalgestationaltreatmentwithmycobacterialantigensonpostnatalimmunityinanexperimentalmurinemodel
AT deganoireneroman influenceofmaternalgestationaltreatmentwithmycobacterialantigensonpostnatalimmunityinanexperimentalmurinemodel
AT singhmahavir influenceofmaternalgestationaltreatmentwithmycobacterialantigensonpostnatalimmunityinanexperimentalmurinemodel
AT fernandezcarmen influenceofmaternalgestationaltreatmentwithmycobacterialantigensonpostnatalimmunityinanexperimentalmurinemodel